The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoprotis induction in transformed cells but not in normal cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 62, Issue 4, 1997, Pages 253-267

  Seegers, Johanna C ^a   Lottering, Mona Liza ^a   Grobler, Christina J S ^a   Van Papendorp, Dirk H ^a   Habbersett, Robert C ^b   Shou, Yulin ^b   Lehnert, Bruce E ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; FLOW CYTOMETRY; GASTRIN CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MICRONUCLEUS; SIMIAN VIRUS 40; SKIN FIBROBLAST; TEMPERATURE;

APOPTOSIS; CELL CYCLE; CELL LINE, TRANSFORMED; DNA; ESTRADIOL; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; G2 PHASE; HUMANS; MITOSIS; TUBULIN; TUBULIN MODULATORS; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0030787134     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00043-5     Document Type: Article

References (43)

1. MacLusky, N. R., Barnes, E. R., Clark, C. R. and Naftolin, F., Catechol estrogens and estrogen receptors. In Catechol Estrogens, ed. M. B. Lipsett and G. R. Merriam. Raven Press, New York, 1983, pp. 151-165.
2. Ball, P., Haupt, M. and Knuppen, R., Biogenesis and metabolism of catechol estrogens in vitro. In Catechol Estrogens, ed. M. B. Lipsett and G. R. Merriam. Raven Press, New York, 1983, pp. 91-103.
3. Seegers J. C., Aveling M.-L., Van Aswegen C. H., Cross M., Koch F. and Joubert W. S., The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32 (1989) 797-809.
4. Lottering M. L., Haag M. and Seegers J. C., Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res. 52 (1992) 5926-5932.
5. Fotsis T., Zhang Y., Pepper M. S., Adlercreutz H., Montesano R., Nawroth P. P. and Schweigerer L., The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368 (1994) 237-239.
6. Cushman M., He H. M., Katzenellenbogen J. A., Lin C. M. Hamel E., Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J. Med. Chem. 38 (1995) 2041-2049.
7. D'Amato R. J., Lin C. M., Flynn E., Folkman J. and Hamel E., 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3964-3968.
8. Ray F. A., Peabody D. S., Cooper J. L., Cram L. S. and Kreamer P. M., SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J. Cell Biochem. 42 (1990) 13-31.
9. Harvey M., Sands A. T., Weiss R. S., Hegi M. E., Wiseman R. W., Pantazis P., Giovanella B. C., Tainsky M. A., Bradley A. and Donehower L. A., In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8 (1993) 2457-2467.
10. Kuerbitz S. J., Plunkett B. S., Walsh W. V. and Kastan M. B., Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7491-7495.
11. Bakalkin G., Yakovleva T., Selivanova G., Magnusson K. P., Szekely L., Kiseleva E., Klein G., Terenius L. and Wiman K. G., P53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 413-417.
12. 1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem. 270 (1995) 11033-11036.
13. Xia F., Wang X., Wang Y.-H., Tsang N.-M., Yandell D. W., Kelsey K. T. and Liber H. L., Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res. 55 (1995) 12-15.
14. Ray F. A., Meyne J. and Kraemer P. M., SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblasts. Mutat. Res. 284 (1992) 265-273.
15. Ray F. A. and Kraemer P.M., Frequent deletions in nine newly immortal human cell lines. Cancer Genet. Cytogenet. 59 (1992) 39-44.
16. Emons, G., Ball, P. and Knuppen, R., Radioimmunoassays of catechol estrogens. In Catechol Estrogens, ed. M. B. Lipsett and G. R. Merriam. Raven Press, New York, 1983, pp. 71-81.
17. Michalovitz D., Halevy O. and Oren M., Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62 (1990) 671-680.
18. Wang Y. and Eckhart W., Phosphorylation sites in the aminoterminal region of mouse p53. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4231-4235.
19. Keren-Tal I., Suh B. S., Dantes A., Linder S., Oren M. and Amsterdam A., Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells. Exp. Cell Res. 218 (1995) 283-295.
20. Chuang J. Y., Lin C. T., Wu C. W. and Lin Y. S., A movable and regulable inactivation function within the central region of a temperature-sensitive p53 mutant. J. Biol. Chem. 270 (1995) 23899-23902.
21. Steinkamp J. A., Habbersett R. C. and Hiebert R. D., Improved multilaser/multiparameter flow cytometer for analysis and sorting of cells and particles. Rev. Sci. Instrum. 62 (1991) 2751-2764.
22. Sherwood S. W. and Schimke R. T., Cell cycle analysis of apoptosis using flow cytometry [Review]. Methods Cell Biol. 46 (1995) 77-97.
23. Endresen P. C., Prytz P. S. and Aarbakke J., A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA. Cytometry 20 (1995) 162-171.
24. Elstein K. H., Thomas D. J. and Zucker R. M., Factors affecting flow cytometric detection of apoptotic nuclei by DNA analysis. Cytometry 21 (1995) 170-176.
25. Del Bino G. and Darzynkiewicz Z., Camptothecin, teniposide or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S-phase of HL-60 cells. Cancer Res. 51 (1991) 1165-1169.
26. 1) leukemic cells. Cancer Res. 50 (1990) 5746-5750.
27. Del Bino G., Bruno S., Yi P. N. and Darzynkiewicz Z., Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif. 25 (1992) 537-548.
28. Eastman A., Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2 (1990) 275-280.
29. Gorczyca W., Gong J., Ardelt B., Traganos F. and Darzynkiewicz Z., The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53 (1993) 3186-3192.
30. Lottering M.-L., de Kock M., Viljoen T. C., Grobler C. J. S. Seegers J. C., 17β-estradiol metabolites affect some regulators of the MCF-7 cell cycle. Cancer Lett. 110 (1996) 181-186.
31. Maxwell S. A., Ames S. K., Sawai E. T., Decker G. L., Cook R. G. and Butel J. S., Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. Cell Growth Diff. 2 (1991) 115-127.
32. Vayssiere J. L., Petit P. X., Risler Y. and Mignotte B., Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11752-11756.
33. Tsukidate K., Yamamoto K., Snyder J. W. and Farber J. L., Microtubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes. Am. J. Pathol. 143 (1993) 918-925.
34. 2/M arrest and apoptosis. Nature Med. 2 (1996) 72-79.
35. Tishler R. B., Lamppu D. M., Park S. and Price B. D., Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55 (1995) 6021-6025.
36. Horwitz S. B., Mechanism of action of taxol. Trends Pharmacol. Sci. 13 (1992) 134-136.
37. cdc-2 activation required for apoptosis. Science 263 (1994) 1143-1145.
38. Heald R., McLoughlin M. and McKeon F., Human Weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74 (1993) 463-474.
39. cdc-2 coincident with taxol-induced apoptosis. Cell Growth Diff. 5 (1994) 1041-1050.
40. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8493-8497.
41. Nelson W. G. and Kastan M. B., DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14 (1994) 1815-1823.
42. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B. and Craig R. W., Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51 (1991) 6304-6311.
43. 1 arrest. Cell 76 (1994) 1013-1023.